Overview
- 3 inspections across 2 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-04-19.
At a glance
Inspections
3
Sites
2
Observations
0
Career since
Oct 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Immunex Rhode Island Corporation | 19 Apr 2019 | Human Drugs | On file |
| Immunex Rhode Island Corporation | 2 Nov 2018 | Human Drugs | On file |
| Boehringer Ingelheim Pharma GmbH and Co. KG | 19 Oct 2018 | Human Drugs |
Sites inspected
Immunex Rhode Island CorporationWest Greenwich, United States2 insp.
Boehringer Ingelheim Pharma GmbH and Co. KGBiberach An Der Ris, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Ziyang Su's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site